Genomic assay may predict long-term prognosis in premenopausal patients with HR-positive early-stage breast cancer
Among premenopausal women with hormone receptor (HR)-positive, early-stage breast cancer enrolled in the SOFT trial, those with a high score on a genomic assay called Breast Cancer Index (BCI) had increased risk of distant ...
Dec 6, 2022
0
12